539680 — GANGA PHARMACEUTICALS Cashflow Statement
0.000.00%
- IN₹64.42m
- IN₹75.61m
- IN₹26.37m
Annual cashflow statement for GANGA PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS |
Standards: | IAS | IAS | — |
Status: | Final | Final | Final |
Net Income/Starting Line | 0.531 | 0.633 | 0.947 |
Depreciation | |||
Non-Cash Items | -1.11 | -0.585 | -2.67 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -0.378 | -13.2 | -4.51 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -0.399 | -12.6 | -5.77 |
Capital Expenditures | -0.148 | -0.224 | -0.987 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | 5.07 | 1.52 | 12.8 |
Sale/Maturity of Investment | |||
Change in Net Investments | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | 4.92 | 1.3 | 11.8 |
Financing Cash Flow Items | -1.87 | -1.81 | -1.69 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | -4.44 | 11.4 | -3.31 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.086 | 0.008 | 2.73 |